Compare ROMA & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ROMA | SGMO |
|---|---|---|
| Founded | 2018 | 1995 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.9M | 155.1M |
| IPO Year | 2024 | 2000 |
| Metric | ROMA | SGMO |
|---|---|---|
| Price | $2.32 | $0.45 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $4.71 |
| AVG Volume (30 Days) | 3.3K | ★ 9.2M |
| Earning Date | 12-26-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,568,345.00 | ★ $32,875,000.00 |
| Revenue This Year | N/A | $1.37 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23.21 | N/A |
| 52 Week Low | $0.58 | $0.38 |
| 52 Week High | $4.66 | $2.84 |
| Indicator | ROMA | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 41.27 | 43.51 |
| Support Level | $2.23 | $0.49 |
| Resistance Level | $2.51 | $0.51 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 41.70 | 31.04 |
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.